Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
US Army
Argus Health
Johnson and Johnson
Express Scripts

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202428

« Back to Dashboard

NDA 202428 describes FABIOR, which is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the FABIOR profile page.

The generic ingredient in FABIOR is tazarotene. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
Summary for 202428
Applicant:Mayne Pharma
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202428
Suppliers and Packaging for NDA: 202428
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FABIOR tazarotene AEROSOL, FOAM;TOPICAL 202428 NDA Stiefel Laboratories, Inc. 0145-0020 0145-0020-03 1 CAN in 1 CARTON (0145-0020-03) > 50 g in 1 CAN
FABIOR tazarotene AEROSOL, FOAM;TOPICAL 202428 NDA Mayne Pharma LLC 51862-295 51862-295-50 1 CAN in 1 CARTON (51862-295-50) > 50 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.1%
Approval Date:May 11, 2012TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Feb 24, 2030Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.